» Articles » PMID: 16740156

Prognostic Value of P27Kip1 Expression in Basaloid Squamous Cell Carcinoma of the Larynx

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2006 Jun 3
PMID 16740156
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Very few reports have investigated the role of cell cycle regulators as biomarkers in Basaloid Squamous Cell Carcinoma (BSCC) of the larynx, a definite morphologic, uncommon, very aggressive variant of squamous cell carcinoma. Lower expression of Ki67/Mib-1, a proliferation marker highly expressed in the majority of tumours, and p53, a tumour suppressor protein that can induce an arrest of the G1-S transition, was related to a better prognosis in laryngeal BSCC. In the head and neck, p27kip1, a member of the Cip1/Kip1 family of cyclin-dependent kinase inhibitors, has emerged as an independent prognostic factor, able to identify low-expressing tumours with unfavourable course. Up to date the role of this protein was never studied in BSCC. Aim of our study was to investigate the potential prognostic value of p27kip1 levels and their correlation with Ki67/Mib-1 and p53 expression in BSCC of the larynx.

Methods: The retrospective study group consisted of 15 male and 1 female patients, affected by laryngeal BSCC, ranging in age from 44 to 69 years (mean 58). The tumour originated from the supraglottis in thirtheen cases and from the glottis in the remaining three. Ten patients had metastatic cervical lymph nodes at presentation and were classified as N+. Post surgical stage was IV in four patients, III in nine, II in two cases and I in the remaining one. Follow-up ranged from a minimum of 5 months up to 9 years. Paraffin-embedded tissue sections of each laryngeal tumour were analyzed for p27kip, Ki67/Mib-1 and p53 expression by immunohistochemistry.

Results: The immunohistochemical study showed p27kip1 expression in 40% of the patients with no evidence of disease (NED) and in none (0%) of the patients dead of disease (DOD), whilst p53 was expressed in 60% of patients in NED status and in 90% of patients in DOD status. Ki67/Mib-1 was positive in 80% of NED patients and in 100% of DOD patients. At multivariate analysis, performed by means of Discriminant analysis, low levels of p27kip1 expression significantly correlated with poor prognosis (P < 0.05).

Conclusion: p27kip1 protein has been shown to be a significant independent prognostic factor in laryngeal SCC. In our series of laryngeal BSCC the resulting data seem to confirm the clinical prognostic relevance of p27kip1 low expression, which directly correlated with biological aggressiveness and consequent shortened survival.

Citing Articles

Tumor-Stroma Ratio in Basaloid and Conventional Laryngeal Squamous Cell Carcinoma: Prognostic Significance and Concordance in Paired Biopsies and Surgical Samples.

Marioni G, Taboni S, Sbaraglia M, Franz L, Saccardo T, Colombo A Cancers (Basel). 2023; 15(6).

PMID: 36980531 PMC: 10046013. DOI: 10.3390/cancers15061645.


Ki67, p27 and p53 Expression in Squamous Epithelial Lesions of Larynx.

Mondal D, Saha K, Datta C, Chatterjee U, Sengupta A Indian J Otolaryngol Head Neck Surg. 2014; 65(2):126-33.

PMID: 24427552 PMC: 3649026. DOI: 10.1007/s12070-012-0590-x.


Basaloid squamous cell carcinoma of retromolar trigone: A case report with review of literature.

Rachel J, Kumar N, Jain N J Oral Maxillofac Pathol. 2012; 15(2):192-6.

PMID: 22529579 PMC: 3329705. DOI: 10.4103/0973-029X.84495.


Basaloid squamous cell carcinoma of the larynx: report of a early laryngeal cancer.

Soprani F, Armaroli V, Stefanelli A, Emiliani E, Padovani D, Casolino D Acta Otorhinolaryngol Ital. 2011; 31(3):181-5.

PMID: 22058594 PMC: 3185819.


Basaloid squamous cell carcinoma of the head and neck: a clinicopathological and follow-up study of 40 cases and review of the literature.

Ereno C, Gaafar A, Garmendia M, Etxezarraga C, Bilbao F, Lopez J Head Neck Pathol. 2010; 2(2):83-91.

PMID: 20614328 PMC: 2807543. DOI: 10.1007/s12105-008-0045-6.


References
1.
Sheen T, Chang Y, Ko J, Wu C, Lee S . Basaloid squamous cell carcinoma of the larynx. Otolaryngol Head Neck Surg. 1999; 121(5):647-50. DOI: 10.1016/S0194-5998(99)70074-4. View

2.
Ozturk O, Sari M, Inanli S, Kara E . Basaloid squamous cell carcinoma of the larynx: a case report. Kulak Burun Bogaz Ihtis Derg. 2006; 15(5-6):125-9. View

3.
Erdamar B, Suoglu Y, Sirin M, Karatay C, KATIRCIOGLU S, Kiyak E . Basaloid squamous cell carcinoma of the supraglottic larynx. Eur Arch Otorhinolaryngol. 2000; 257(3):154-7. DOI: 10.1007/s004050050213. View

4.
Paulino A, Singh B, Shah J, Huvos A . Basaloid squamous cell carcinoma of the head and neck. Laryngoscope. 2000; 110(9):1479-82. DOI: 10.1097/00005537-200009000-00013. View

5.
Assimakopoulos D, Kolettas E, Zagorianakou N, Evangelou A, Skevas A, Agnantis N . Prognostic significance of p53 in the cancer of the larynx. Anticancer Res. 2000; 20(5B):3555-64. View